Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conducting Oncology Clinical Trials in Africa II: AC3T - Assessing, profiling, and building cancer clinical trial capacity in Africa

Published: 27 May 2020

Views: 3135

Rating:

Save

Daniel Seymour - BIO Ventures for Global Health, Seattle, USA

In this week's webinar (hosted by the African Clinical Trials Consortium), Daniel Seymour from BIO Ventures for Global Health speaks about strategies for building needed research infrastructure for clinical trials.

To fullscreen the video to view the slides click the 4 arrow icon in the bottom right of the video player.

Download the webinar slides here.

The other webinars in the series can be found here.

Watch the Meet the Expert session with Daniel Seymour here.

Related Videos

Innovating cancer care access for low and middle-income countries

Lacy Hubbard - Founding President and CEO, Elekta Foundation

Innovating cancer care access for low and middle-income countries ( Lacy Hubbard - Founding President and CEO, Elekta Foundation )

Prostate cancer

Dr Alison Tree - Institute of Cancer Research, London, UK

Prostate cancer ( Dr Alison Tree - Institute of Cancer Research, London, UK )

Rectal cancer

Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada

Rectal cancer ( Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada )

Breast cancer

Dr Sofia Rivera - Gustave Roussy, Villejuif, France

Breast cancer ( Dr Sofia Rivera - Gustave Roussy, Villejuif, France )

Introducing oncology to undergraduate medical and allied health sciences students

Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India

Introducing oncology to undergraduate medical and allied health sciences students ( Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India )

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )

The use of IORT at Universitätsmedizin Mannheim hospital

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany

The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )

More from ecancer